---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-005124"
form_type: "8-K"
ticker: "FLGT"
cik: "0001674930"
company_name: "Fulgent Genetics, Inc."
filed_at: "2023-02-28T23:59:59+00:00"
generated_at: "2026-06-18T22:21:17.621954+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Fulgent Genetics Q4 2022 GAAP loss $0.80/share; core revenue up 97% YoY to $55M

## Summary
- Q4 total revenue $67.7M; core revenue (ex-COVID) $55.0M, up 97% YoY.
- GAAP net loss $23.8M ($0.80 per share); non-GAAP loss $14.2M ($0.48 per share).
- Full year 2022 core revenue $181.5M, up 95% YoY; total revenue $619.0M.
- Cash and investments $872.0M as of Dec 31, 2022; repurchased 815k shares in Q4.
- Full year GAAP net income $143.4M ($4.63 per share); adjusted EBITDA $257.1M.

## SEC filing metadata
- accession: 0000950170-23-005124
- form_type: 8-K
- ticker: FLGT
- cik: 0001674930
- company_name: Fulgent Genetics, Inc.
- filed_at: 2023-02-28T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1674930/000095017023005124/0000950170-23-005124-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1674930/000095017023005124/flgt-20230228.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-005124
- JSON: https://secwatch.observer/filing/0000950170-23-005124.json
- Plain text: https://secwatch.observer/filing/0000950170-23-005124.txt

## Key facts
- Earnings Releases
  Fulgent Genetics, Inc. reported the fiscal quarter and year ended December 31, 2022 results: revenue $619.0 million, net income GAAP income of $143.4 million, EPS $4.63 per share.
  - Period: the fiscal quarter and year ended December 31, 2022
  - Revenue: $619.0 million
  - Net income: GAAP income of $143.4 million
  - EPS: $4.63 per share
  - Result: reported results
  source text: Current Report on Form 8-K. --- EX-99 (EX-99.1) --- EX-99 Exhibit 99.1 Fulgent Reports Fourth Quarter and Full Year 2022 Financial Results • Full Year 2022 Total Revenue of $619.0 million; Q4 Total Revenue of $67.7 million • Full Year 2022 Core Revenue grows 95% year-over-year to $181.5 million; Q4 Core Revenue grows 97% year-over-year to $55.0 million TEMPLE
  evidence_url: https://www.sec.gov/Archives/edgar/data/1674930/000095017023005124/0000950170-23-005124-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.